共 5 条
- [1] A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis[J]. CLINICAL TRANSPLANTATION, 2002, 16 (01) : 60 - 68Stratta, RJAlloway, RRHodge, ELo, A
- [2] A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis[J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1903 - 1905Stratta, RJAlloway, RRHodge, ELo, A
- [3] A multicenter trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: Interim analysis[J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1692 - 1693Stratta, RJAlloway, RRLo, AHodge, E
- [4] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil regimen (MMF) in De novo renal allograft recipients: Acute rejection and graft survival results from the orion study[J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 209 - 210Flechner, StuartGlyda, MaciejSteinberg, StevenHarler, Mary Beth
- [5] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SR-L) regimens with a tacrolimus (Tac) and mycophenolate mofetil regimen (MMF) in de novo renal allograft recipients: Acute rejection and graft survival results from the ORION study.[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 160 - 160Flechner, StuartGlyda, MaciejSteinberg, StevenHarler, M. B.